BK virus-specific immune monitoring to predict BK viruria, BK viremia and BK virus-associated nephropathy after kidney transplantation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20190404004

Enrollment

100

Registered

2019-04-04

Start date

2019-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

BK virus&#45

Interventions

Adult kidney transplant recipients in Ramathibodi hospital

Prevention

Kidney transplant recipients

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: All kidney transplant recipients in Ramathibodi hospital who informed consent.

Exclusion criteria

Exclusion criteria: Those who declined to inform a consent or request to withdraw from the project.

Design outcomes

Primary

Measure	Time frame
BK-specific Immunity 0, 1 and 3 months Intracellular cytokine assay	—

Secondary

Measure	Time frame
BK viruria, BK viremia, BKVAN 0,1,3,6,9,12 months PCR	—

Countries

Thailand

Contacts

Public ContactJackrapong Bruminhent

Faculty of Medicine Ramathibodi Hospital, Mahidol University

jbruminhent@gmail.com022011581

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

BK virus&#45;specific immune monitoring to predict BK viruria&#44; BK viremia and BK virus&#45;associated nephropathy after kidney transplantation